Pediatrix Medical Group Reports Strong Full-Year 2025 Profit Turnaround and Positive 2026 Outlook
MD sits 74% above its 52-week low of $11.84.
Summary
Pediatrix Medical Group announced a significant financial turnaround for full-year 2025, swinging from a net loss to substantial net income, alongside improved cash flow and a positive Adjusted EBITDA outlook for 2026.
Key Events · Earnings and Guidance · MD
-
Full-Year Profitability Achieved
The company swung from a net loss of $99.1 million in 2024 to a net income of $165.4 million for the full year ended December 31, 2025.
-
Significant Adjusted EBITDA Growth
Full-year Adjusted EBITDA increased substantially to $275.6 million in 2025, up from $224.0 million in the prior year.
-
Positive 2026 Outlook Provided
Pediatrix anticipates preliminary 2026 Adjusted EBITDA to be in the range of $280 million to $300 million.
-
Improved Financial Position
The company ended 2025 with increased cash and cash equivalents of $375.2 million and reduced total debt to $597 million, with no outstanding borrowings under its revolving line of credit.
Analysis · MD · Industrial Applications And Services
This filing reveals a significant financial turnaround for Pediatrix Medical Group in 2025, marked by a substantial shift from a net loss to considerable net income. This robust recovery, combined with improved cash flow, reduced debt, and a positive Adjusted EBITDA outlook for 2026, indicates enhanced operational efficiency and financial stability. Investors will likely view the return to profitability as a strong signal that the company's strategic initiatives are yielding positive results, despite some mixed performance in the fourth quarter. The provided 2026 guidance offers a clear trajectory for continued growth.
At the time of this filing, MD was trading at $20.65 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $11.84 to $24.99. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.